secwatch.observer — SEC 8-K summary
======================================

Issuer:     Microbot Medical Inc. (MBOT)
CIK:        0000883975
Form:       8-K
Filed at:   2026-03-17T23:59:59+00:00
Accession:  0001493152-26-010446
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Microbot Medical to present at Roth Conference; full LIBERTY market release on track for April 2026
--------------------------------------------------------------------------------

- CEO Harel Gadot to present fireside Q&A at Roth Annual Growth Conference on March 23, 2026 at 4:00 pm PT.
- Limited market release of LIBERTY Endovascular Robotic System began in late 2025; full market release targeted at SIR conference in April 2026.
- LIBERTY is the only FDA-cleared, single-use, remotely operated robotic system for peripheral endovascular procedures.
- Company highlights multi-site customer traction and procedural diversity during limited release phase.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/883975/000149315226010446/0001493152-26-010446-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/883975/000149315226010446/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-010446

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer